RDY
Dr. Reddy’s Laboratories Ltd ADR
NYSE: RDY · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$13.73
-2.14% today
Updated 2026-04-29
Market cap
$11.46B
P/E ratio
19.07
P/S ratio
0.03x
EPS (TTM)
$0.72
Dividend yield
0.67%
52W range
$13 – $16
Volume
2.4M
Dr. Reddy’s Laboratories Ltd ADR (RDY) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+28.6%
Last 4 quarters
Revenue YoY growth
+4.4%
Most recent quarter
EPS YoY growth
-99.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+3.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+6.0%
2026-01-21
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-01-21 | $0.16 | +1.9% | $12.94 | $13.71 | +6.0% |
| 2025-11-05 | $0.20 | -98.9% | $13.47 | $13.47 | +0.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.16 | $0.16 | +1.9% | $87.27B | +4.4% |
| 2025-09-30 | $18.31 | $0.20 | -98.9% | $88.05B | +9.8% |
| 2025-06-30 | $0.21 | $17.02 | +8004.8% | $85.45B | +11.4% |
| 2025-03-31 | $17.13 | $19.11 | +11.6% | $85.06B | +20.1% |
| 2024-12-31 | $16.15 | $16.94 | +4.9% | $83.59B | +15.9% |
| 2024-09-30 | $17.69 | $15.83 | -10.5% | $80.16B | +9532.6% |
| 2024-06-30 | $78.22 | $83.46 | +6.7% | $76.73B | +13.9% |
| 2024-03-31 | $68.45 | $78.35 | +14.5% | $70.83B | — |
| 2023-12-31 | $70.43 | $82.81 | +17.6% | $72.15B | — |
| 2023-09-30 | $69.65 | $88.91 | +27.7% | $832.20M | — |
| 2023-06-30 | $0.21 | $0.21 | -2.1% | $67.38B | — |
Frequently asked questions
Has Dr. Reddy’s Laboratories Ltd ADR beaten earnings estimates?
Dr. Reddy’s Laboratories Ltd ADR has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +28.6% over the last 4 quarters.
How does RDY stock react to earnings?
RDY stock has moved an average of +3.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Dr. Reddy’s Laboratories Ltd ADR's revenue growth rate?
Dr. Reddy’s Laboratories Ltd ADR reported year-over-year revenue growth of +4.4% in its most recent quarter, with EPS growing -99.0% year-over-year.